Chugai Pharmaceutical Co., Ltd...
TSE:4519
¥ 5,090.00
+ ¥25.00 (0.49%)
¥ 5,090.00
+ ¥25.00 (0.49%)
End-of-day quote: 04/18/2024

4519 - Chugai Pharmaceutical Stock Prediction 2025 - 2030

20 years of reliable Chugai Pharmaceutical stock forecast. The Wall Street analysts predict Outperform for 4519. See at a glance whether TSE:4519 will rise in the future.

Forecast 2023
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
Forecast 2030
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.48
Price-to-book Ratio
5.15
Market Cap
8,374.65B
TEV
7,691.61 B
Dividend
¥82.46
Div Yld
1.62%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥4,917.14
Country

Chugai Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Chugai Pharmaceutical Stock Forecast 2023

¥6,150.00

In the last five quarters, Chugai Pharmaceutical’s Price Target has risen from ¥3,609.17 to ¥4,917.14 - a 36.24% increase.

20.83%
20.83
Last update: 04/19/2024

Highest Price Target ¥7,410.00

Average Price Target ¥6,150.00

Lowest Price Target ¥4,500.00

Chugai Pharmaceutical Stock Predictions 2025

Chugai Pharmaceutical Stock Prediction 2030

P/E
0.00
Beta
0.48
Price-to-book Ratio
5.15
Market Cap
8,374.65B
TEV
7,691.61 B
Dividend
¥82.46
Div Yld
1.62%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥4,917.14
Country

Chugai Pharmaceutical Analyst Ratings Frequently Asked Questions

Who are the analysts watching Chugai Pharmaceutical Co., Ltd.?

The following analysts have recently covered Chugai Pharmaceutical:

BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Mizuho Securities Co., Ltd.
Morgan Stanley
Morningstar Inc.
Nomura Securities Co. Ltd.
Pathology Associates Co., Ltd.
Sanford C. Bernstein & Co., LLC
SMBC NIKKO
UBS Investment Bank
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Chugai Pharmaceutical Co., Ltd.?

The following sell-side analysts have recently covered Chugai Pharmaceutical:

Mamegano, Koichi
Bahari, Hazim
Yamaguchi, Hidemaru
Hashiguchi, Kazuaki
Ueda, Akinori
Wakao, Seiji
Barker, Stephen
Paraskevopoulos, Michail
Tanaka, Hiroshi
Muraoka, Shinichiro
Lee, Jay
Matsubara, Hiroyuki
Büchner, Dion Stéfan
Sogi, Miki
Wada, Hiroshi
Sakai, Fumiyoshi
(This information refers to the last 90 days.)